Trials / Completed
CompletedNCT00210106
Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy.
Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. A Phase 2 Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Institut Bergonié · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis is that radiofrequency ablation combined or not with resection may allow a local control (the liver) in patients suffering from unresectable colorectal liver metastases. Patients may have benefit or not from a preoperative (neoadjuvant) chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ablathermy |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2008-12-01
- Completion
- 2010-05-01
- First posted
- 2005-09-21
- Last updated
- 2021-05-18
- Results posted
- 2021-05-18
Locations
12 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00210106. Inclusion in this directory is not an endorsement.